Deutsche Bank AG Has $1.66 Million Stake in Aspen Aerogels, Inc. $ASPN

Deutsche Bank AG reduced its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 37.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 259,553 shares of the construction company’s stock after selling 155,838 shares during the quarter. Deutsche Bank AG owned about 0.32% of Aspen Aerogels worth $1,659,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of ASPN. Millennium Management LLC grew its stake in shares of Aspen Aerogels by 4,757.8% during the fourth quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after purchasing an additional 1,588,632 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $13,122,000. Alyeska Investment Group L.P. bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $9,504,000. Two Sigma Investments LP grew its stake in shares of Aspen Aerogels by 637.9% during the fourth quarter. Two Sigma Investments LP now owns 592,765 shares of the construction company’s stock valued at $7,042,000 after purchasing an additional 512,439 shares during the last quarter. Finally, New York State Common Retirement Fund grew its stake in shares of Aspen Aerogels by 2,073.6% during the first quarter. New York State Common Retirement Fund now owns 437,572 shares of the construction company’s stock valued at $2,796,000 after purchasing an additional 417,441 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Price Performance

Shares of ASPN stock opened at $6.9750 on Friday. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $32.31. The stock has a market cap of $574.46 million, a PE ratio of -1.83 and a beta of 2.73. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. The firm’s 50 day moving average price is $6.91 and its two-hundred day moving average price is $6.79.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The firm had revenue of $78.02 million for the quarter, compared to analysts’ expectations of $72.53 million. During the same period last year, the firm earned $0.21 earnings per share. The business’s revenue for the quarter was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. As a group, analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on ASPN shares. Oppenheimer cut shares of Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 8th. Barclays cut shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and increased their price target for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Finally, Canaccord Genuity Group decreased their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $19.50.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the firm’s stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer directly owned 19,879 shares of the company’s stock, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.30% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.